Market Tracker

07/28 4:29pm ET

InterMune Inc (NASDAQ:ITMN)

During the Trading Day
44.34 -1.16 / -2.55%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
44.35 +0.01 / +0.02%
 
Volume: --

Today’s Trading

Previous close45.50
Today’s open45.45
Day’s range44.11 - 45.66
Volume1,251,260
Average volume (3 months)2,190,017
Market cap$4.5B
Dividend yield--
Data as of 3:59pm ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)+14.26%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book30.36

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.33+0.78%
XONIntrexon Corp-1.49-6.16%
GEVASynageva BioPharma C...-3.08-4.26%
OPHTOphthotech Corp-1.37-3.37%
Data as of 4:07pm ET, 07/28/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts